Table 3:
MRI and cognitive function measures in African American–Diabetes Heart Study MIND
| Variable | Mean | SD | No. |
|---|---|---|---|
| MRI results | |||
| GM volume, unadjusted (mL) | 732.2 | 57.7 | 263 |
| GM/ICV (%)a | 43.3 | 2.8 | 263 |
| WM volume, unadjusted (mL) | 629.6 | 46.7 | 263 |
| WM/ICV (%)a | 37.3 | 2.3 | 263 |
| WM lesion volume (mL) | 7.9 | 14.7 | 263 |
| Cognitive function measures | |||
| 3MSE (score, 0–100) | 84.6 | 9.0 | 256 |
| MoCA (score, 0–30) | 19.9 | 3.9 | 261 |
| RAVLT (score, 0–75) | 38.0 | 9.0 | 263 |
| DSC (score, 0–133) | 48.1 | 15.9 | 262 |
| VFA | 15.7 | 4.6 | 262 |
| Stroop errors | 3.4 | 6.3 | 258 |
| Stroop interference (seconds; trial 3 to trial 2) | 31.6 | 16.1 | 256 |
| CESD | 8.0 | 5.3 | 262 |
| BSI-Anxiety | 4.9 | 4.5 | 262 |
Note:—ICV indicates intracranial volume; 3 MSE, modified MMSE; RAVLT, Rey Auditory Verbal Learning Test; CESD, Center for Epidemiologic Studies Depression Scale; BSI-Anxiety, Brief Symptom Inventory.
a
Whole-brain measures adjusted for total ICV.